The company operates in two distinct segments: real estate development and leasing of industrial properties in Madhya Pradesh, alongside an investment division that manages a portfolio of quoted and unquoted securities.
The company lacks a durable competitive advantage, as evidenced by low average ROCE (6.3%) and ROE (4.8%). While it benefits from owning land in the Indore-Dewas corridor, its earnings are highly volatile and dependent on capital market fluctuations rather than operational pricing power.
Capital has been deployed into low-yielding real estate projects and a fragmented equity portfolio. The recent shift toward heavy capital expenditure in industrial sheds has yet to demonstrate superior incremental returns, and the company does not pay dividends despite high cash conversion.
Five years out, the capital allocated to industrial sheds and real estate failed to clear the cost of capital, while the equity portfolio suffered during a market downturn, exposing the company's lack of a core operating engine. The death of key leadership left a vacuum that was filled by high-cost management who continued to prioritize related-party land deals over shareholder returns. With no dividends and stagnant earnings, the market eventually re-rated the stock to a deep discount against its book value, realizing the land bank was a non-productive asset rather than a growth catalyst.
RichFakir rates Sam Industries Ltd's business quality as poor — 25/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Sam Industries Ltd is trading about 1% below our estimate of fair value; we rate its price fair. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Sam Industries Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Sam Industries Ltd's fair value is about ₹33 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →